Inhaled fluticasone reduces <font color="red">sputum_1</font> <font color="red">inflammatory_1</font> <font color="red">indices_1</font> in severe bronchiectasis . 
<br>
<br> Although corticosteroid therapy might be clinically beneficial for bronchiectasis , very little is known of its effects on the <font color="red">inflammatory_1</font> <font color="red">and_1</font> <font color="red">infective_1</font> <font color="red">markers_1</font> in bronchiectasis . We have therefore performed a double - blind , placebo - controlled study to evaluate the effects of a 4-wk administration of inhaled fluticasone in bronchiectasis . Twenty - four patients ( 12 female ; mean age 51 yr ) were randomized into receiving either inhaled fluticasone ( 500 microgram twice daily ) via the Accuhaler device ( n = 12 ) or placebo . At each visit , <font color="red">spirometry_1</font> <font color="red">,_1</font> <font color="red">24-h_1</font> <font color="red">sputum_1</font> <font color="red">volume_1</font> <font color="red">,_1</font> <font color="red">sputum_1</font> <font color="red">leukocyte_1</font> <font color="red">density_1</font> <font color="red">,_1</font> <font color="red">bacterial_1</font> <font color="red">densities_1</font> <font color="red">,_1</font> and <font color="red">concentrations_1</font> <font color="red">of_1</font> <font color="red">interleukin_1</font> <font color="red">(_1</font> <font color="red">IL)-1beta_1</font> <font color="red">,_1</font> <font color="red">IL-8_1</font> <font color="red">,_1</font> <font color="red">tumor_1</font> <font color="red">necrosis_1</font> <font color="red">factor_1</font> <font color="red">-_1</font> <font color="red">alpha_1</font> <font color="red">(_1</font> <font color="red">TNF_1</font> <font color="red">-_1</font> <font color="red">alpha_1</font> <font color="red">)_1</font> <font color="red">,_1</font> and <font color="red">leukotriene_1</font> <font color="red">B4_1</font> <font color="red">(_1</font> <font color="red">LTB4_1</font> <font color="red">)_1</font> were determined . There was a significant ( p < 0.05 ) decrease in <font color="red">sputum_1</font> <font color="red">leukocyte_1</font> <font color="red">density_1</font> and <font color="red">IL-1beta_1</font> <font color="red">,_1</font> <font color="red">IL-8_1</font> <font color="red">,_1</font> and <font color="red">LTB4_1</font> after fluticasone treatment . The fluticasone group had one and the placebo group three episodes of exacerbation . There were no significant changes in <font color="red">spirometry_1</font> ( p > 0.05 ) or any <font color="red">reported_1</font> <font color="red">adverse_1</font> <font color="red">reactions_1</font> in either group . The results of this study show that high - dose fluticasone is effective in reducing the <font color="red">sputum_1</font> <font color="red">inflammatory_1</font> <font color="red">indices_1</font> in bronchiectasis . Large - scale and long - term studies are indicated to evaluate the effects of inhaled steroid therapy on the inflammatory components in bronchiectasis .